Phospho-STK3/STK4 (T183) Antibody

What are STK3/STK4 kinases and what is the significance of their T183 phosphorylation?

STK3 (also known as MST2) and STK4 (also known as MST1) are serine/threonine kinases that function as key components of the Hippo signaling pathway. They are activated by proapoptotic molecules and function as growth suppressors . Phosphorylation at threonine 183 (T183) of STK4 (or the equivalent T180 in STK3) is a critical activation event that indicates kinase activity. This phosphorylation is important because:

• It marks the active state of these kinases

• It increases significantly (approximately 3-fold) during cellular starvation conditions

• It plays a crucial role in the Hippo pathway activation following serum deprivation

• It serves as a regulatory mechanism for downstream processes including autophagy and apoptosis

The phosphorylation state at these threonine residues therefore provides a reliable readout of STK3/STK4 activity in various experimental conditions.

How does STK4 phosphorylation relate to autophagy regulation?

STK4 phosphorylation plays a significant regulatory role in autophagy through its interaction with LC3B. Research has demonstrated that:

• Nutrient deprivation regulates an STK4-LC3B-FYCO1 axis to control the subcellular positioning of autophagosomes

• STK4 phosphorylates LC3B at threonine 50 (T50)

• This phosphorylation reduces the binding affinity between LC3B and FYCO1, a protein important for autophagosome transport

• Depletion of STK4 or expression of phospho-mutant LC3B affects autophagy dynamics

• STK4-dependent phosphorylation of LC3B is required for starvation-induced perinuclear autophagosome positioning

These findings highlight STK4 as a crucial regulator of autophagosome positioning and autophagy progression in response to nutrient conditions.

What experimental systems are suitable for studying STK3/STK4 phosphorylation?

Based on the literature, several experimental systems have been successfully employed to study STK3/STK4 phosphorylation:

• Cell lines: Human embryonic kidney (HEK293) cells have been used to study STK4/STK3 phosphorylation

• Mouse embryonic fibroblasts (MEFs) are suitable for studying the effect of STK4 depletion on LC3B binding to FYCO1

• Primary tissues: Human brain tissue sections have been successfully used for immunohistochemical staining with phospho-specific antibodies

• In vitro systems: Purified proteins and peptides can be used for direct binding assays and phosphorylation studies

These systems provide complementary approaches to investigate STK3/STK4 phosphorylation in different contexts, from molecular interactions to cellular responses.

How can researchers distinguish between STK3 and STK4 phosphorylation in experimental settings?

Distinguishing between STK3 and STK4 phosphorylation presents a significant challenge due to their high sequence similarity, particularly at their phosphorylation sites. Advanced approaches include:

• Using isoform-specific siRNA knockdown: Selectively depleting STK3 or STK4 allows researchers to attribute observed phenotypes to specific isoforms

• Complementation studies: Expressing siRNA-resistant wild-type or phospho-mutant versions of either STK3 or STK4 in knockdown cells to confirm specificity

• Mass spectrometry: Employing phosphoproteomic analysis to identify isoform-specific phosphopeptides with high resolution

• Combining phospho-specific antibodies with other techniques: Using the phospho-STK3/STK4 antibodies in conjunction with isoform-specific total protein antibodies in sequential immunoblotting

It's important to note that many commercial antibodies (including those described in the search results) recognize both STK3 and STK4 when phosphorylated at their respective threonine residues, necessitating these additional experimental controls.

What is the relationship between STK3/STK4 phosphorylation and the Hippo signaling pathway in stress responses?

The phosphorylation of STK3/STK4 represents a critical regulatory step in Hippo pathway activation during cellular stress:

• Serum deprivation induces approximately 3-fold increase in phosphorylated (active) STK4 (STK4-pT183), consistent with Hippo pathway activation

• This activation is linked to the regulation of autophagy through the STK4-LC3B-FYCO1 axis

• STK3/STK4 activation via phosphorylation occurs in response to various stress conditions, including starvation, chemical treatments, heat shock, and exposure to apoptosis-inducing agents

• The activated kinases facilitate cellular adaptation to unfavorable environmental conditions through multiple downstream pathways

• Full activation of STK3/STK4 involves caspase-mediated cleavage that removes the inhibitory C-terminal portion, allowing the N-terminal portion to translocate to the nucleus where it homodimerizes to form the active kinase

Understanding these relationships provides insights into how cells coordinate stress responses through integrated signaling networks.

How does the phosphorylation-dependent interaction between LC3B and FYCO1 regulate autophagosome positioning?

The regulation of autophagosome positioning through phosphorylation-dependent interactions represents a sophisticated control mechanism:

• LC3B-T50 phosphorylation by STK4 directly decreases the binding affinity of LC3B for FYCO1

• Biolayer interferometry measurements show binding affinities in the micromolar range (KD ~4.1 × 10^-6 M) between LC3B-WT and FYCO1's LC3-interacting region (LIR)

• Within the LC3B-FYCO1 binding interface, LC3B's T50 residue is positioned near two aspartic acid residues of FYCO1, suggesting a mechanism whereby phosphorylation disrupts this interaction

• This regulatory mechanism is specific to FYCO1, as other LC3B interactors like KEAP1 and p62 bind to LC3B independently of T50 phosphorylation status

• Starvation alters the subcellular localization of LC3B-positive puncta (autophagosomes) in an STK4-dependent manner, with depletion of STK4 preventing starvation-induced perinuclear clustering

These findings reveal a phosphorylation-dependent molecular switch that controls autophagosome trafficking during nutrient stress.

What are the optimal conditions for using phospho-STK3/STK4 (T183) antibodies in Western blotting?

For optimal Western blotting results with phospho-STK3/STK4 (T183) antibodies, researchers should consider the following protocol parameters:

• Sample preparation: Cell lysates should be prepared with phosphatase inhibitors to preserve phosphorylation states

• Dilution range: Antibodies are typically effective at dilutions between 1:500-1:3000 for Western blotting applications

• Controls: Include both untreated and peptide-treated lysates as controls. For instance, comparing untreated 293 cell lysates with synthesized peptide-treated 293 cell lysates

• Protein loading: Approximately 60 kDa is the expected molecular weight for detecting phosphorylated STK3/STK4

• Buffer conditions: Phosphate-buffered saline (PBS) without Mg²⁺ and Ca²⁺, containing 150 mM NaCl at pH 7.4 is recommended for optimal antibody performance

• Storage: Store antibodies at -20°C, preferably in aliquots to avoid repeated freeze-thaw cycles that can affect antibody stability

Following these guidelines will help ensure specific detection of phosphorylated STK3/STK4 proteins in experimental samples.

What approaches can be used to validate the specificity of phospho-STK3/STK4 (T183) antibody staining?

Validating antibody specificity is crucial for reliable experimental outcomes. Several complementary approaches are recommended:

• Peptide competition assays: Pre-incubating the antibody with the phosphorylated peptide immunogen should abolish specific staining in both Western blotting and immunohistochemistry applications

• Phosphatase treatment: Treating samples with lambda phosphatase to remove phosphate groups should eliminate staining with phospho-specific antibodies

• Genetic validation: Using cells with STK3/STK4 knockout or knockdown to confirm absence of staining

• Phospho-mutant expression: Comparing cells expressing wild-type STK3/STK4 with those expressing T183A mutants (which cannot be phosphorylated at this site)

• Physiological validation: Confirming increased phospho-STK3/STK4 signal under conditions known to activate the kinases, such as serum starvation (which should show approximately 3-fold increase)

Implementing multiple validation approaches strengthens confidence in the specificity of observed staining patterns.

What immunohistochemistry protocols yield optimal results with phospho-STK3/STK4 (T183) antibodies?

For successful immunohistochemical detection of phosphorylated STK3/STK4 in tissue sections:

• Fixation: Use formalin/PFA-fixed paraffin-embedded tissue sections

• Antibody dilution: Optimal dilution range for immunohistochemistry is typically 1:50-1:100

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer is recommended to expose phospho-epitopes that may be masked during fixation

• Controls: Include adjacent sections treated with competing phosphopeptide as negative controls

• Visualization: Standard DAB (3,3'-diaminobenzidine) detection systems are suitable for visualizing the bound antibody

• Counterstaining: Light hematoxylin counterstaining allows visualization of tissue architecture without obscuring specific staining

Research has successfully applied these protocols to human brain tissue sections, demonstrating the utility of these antibodies for examining STK3/STK4 phosphorylation in situ .

How can researchers use phospho-STK3/STK4 antibodies to investigate the STK4-LC3B-FYCO1 axis in autophagy regulation?

To investigate the STK4-LC3B-FYCO1 regulatory axis in autophagy, researchers can implement the following experimental approaches:

• Co-immunoprecipitation: Use phospho-STK3/STK4 antibodies to immunoprecipitate the active kinases and blot for LC3B to detect interactions

• Proximity ligation assays: Visualize the spatial relationship between phosphorylated STK3/STK4 and LC3B or FYCO1 in situ

• Starvation experiments: Monitor changes in STK3/STK4 phosphorylation (which should increase approximately 3-fold) and correlate with autophagosome positioning

• Microscopy: Combine immunofluorescence using phospho-STK3/STK4 antibodies with LC3B staining to track autophagosome distribution during nutrient deprivation

• Pharmacological manipulation: Use kinase inhibitors or activators to modulate STK3/STK4 activity and observe effects on the LC3B-FYCO1 interaction

• Mutational analysis: Compare cells expressing wild-type LC3B versus T50A (phospho-null) or T50E (phospho-mimetic) mutants to dissect the role of phosphorylation in the interaction

This multi-faceted approach enables comprehensive analysis of how STK3/STK4 phosphorylation regulates autophagy through the LC3B-FYCO1 interaction.

How can phospho-STK3/STK4 antibodies be integrated into high-throughput phosphoproteomic studies?

Integration of phospho-STK3/STK4 antibodies into high-throughput phosphoproteomic studies requires careful consideration of experimental design:

• Antibody-based enrichment: Phospho-STK3/STK4 antibodies can be used to enrich for phosphorylated forms prior to mass spectrometry analysis

• Validation of MS/MS findings: These antibodies serve as excellent tools to confirm mass spectrometry-identified phosphorylation events

• Kinase-substrate relationship mapping: When used in conjunction with protein microarrays (as described for 289 human kinases), these antibodies can help validate constructed phosphorylation networks

• Activity-based profiling: Measuring phospho-STK3/STK4 levels across multiple conditions can provide activity signatures that correlate with biological outcomes

• Integration with motif analysis: Combining phospho-antibody data with algorithms like M3 (Motif discovery based on Microarray and MS/MS) can help identify consensus phosphorylation motifs for STK3/STK4

These applications extend the utility of phospho-STK3/STK4 antibodies beyond traditional Western blotting and immunohistochemistry into systems-level analyses of phosphorylation networks.

What are the challenges in interpreting phospho-STK3/STK4 antibody data in the context of the Hippo pathway?

Interpreting data from phospho-STK3/STK4 antibodies requires awareness of several complexities:

• Pathway crosstalk: STK3/STK4 phosphorylation can be influenced by multiple upstream signals beyond the canonical Hippo pathway

• Temporal dynamics: The timing of STK3/STK4 phosphorylation may vary across experimental conditions, necessitating time-course studies

• Feedback mechanisms: Active STK3/STK4 can influence their own phosphorylation status through feedback loops

• Subcellular localization: Phosphorylated STK3/STK4 may localize to different cellular compartments, affecting interpretation of immunostaining patterns

• Isoform specificity: Most phospho-antibodies detect both STK3 and STK4 when phosphorylated, making it challenging to distinguish isoform-specific functions

• Context-dependent functions: The biological significance of STK3/STK4 phosphorylation may vary across cell types and physiological conditions

Researchers should incorporate appropriate controls and complementary approaches to address these challenges when interpreting phospho-STK3/STK4 antibody data.